David H. Koch Center for Cancer Care at Memorial Sloan Kettering is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, Post-Polycythemia Vera Myelofibrosis.
Sponsors: Ajax Therapeutics, Inc., H. Lee Moffitt Cancer Center and Research Institute.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering has 2 clinical trials on record, with 2 currently active. Their work covers Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, Post-Polycythemia Vera Myelofibrosis.
David H. Koch Center for Cancer Care at Memorial Sloan Kettering has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.